drugset / Trial / NCT07776405

A Double-Blinded Study on Rapid and Sustained Pain Relief Topical Cannabidiol for Plantar Fasciitis

NCT07776405 ↗

Phase 2 Not yet recruiting 50 enrolled University of Florida
RandomizedParallel-groupSingle-blindTreatment

Summary

This prospective, double-blinded, placebo-controlled study evaluates the efficacy of a 6000 mg transdermal CBD cream in adults with plantar fasciitis. Fifty participants will apply either CBD or placebo once daily for one month.

Timeline

Start
2026-09-01
Primary completion
2027-03-31
Completion
2027-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabidiol Other / unclassified 6000 mg Topical

Indications